Oncopharmpod
Revumenib
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:14:52
- Mas informaciones
Informações:
Sinopsis
The 1st menin inhibitor, revumenib, is approved for relapsed/refractory acute leukemias. Understanding the Pathway: https://doi.org/10.1200/JCO-24-01265
